Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

LPTX - Leap Therapeutics Inc


IEX Last Trade
2.895
0.065   2.245%

Share volume: 45,757
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$2.83
0.07
2.30%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
29%
Profitability 43%
Dept financing 15%
Liquidity 50%
Performance 15%
Company vs Stock growth
vs
Performance
5 Days
6.62%
1 Month
33.03%
3 Months
22.88%
6 Months
1.75%
1 Year
26.09%
2 Year
-79.14%
Key data
Stock price
$2.90
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$1.24 - $5.00
52 WEEK CHANGE
$0.31
MARKET CAP 
110.967 M
YIELD 
N/A
SHARES OUTSTANDING 
38.264 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
BETA 
1.12
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$67,042
AVERAGE 30 VOLUME 
$116,262
Company detail
CEO:
Region: US
Website: https://www.leaptx.com/
Employees: 34
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via http://www.investors.leaptx.com.

Recent news